Mutation of K-RAS protooncogene and loss of heterozygosity on 6q27 in serous and mucinous ovarian carcinomas

Cancer Genetics and Cytogenetics

Volumn 118, Issue 2, 2000, Pages 132-135

  Suzuki, Mitsuaki ^a   Saito, Susumu ^b   Saga, Yasushi ^a   Ohwada, Michitaka ^a   Sato, Ikuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b SRL INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; OVARY CARCINOMA; POINT MUTATION; PRIORITY JOURNAL; PROTO ONCOGENE; SOUTHERN BLOTTING;

ADENOCARCINOMA, MUCINOUS; CHROMOSOMES, HUMAN, PAIR 6; CODON; FEMALE; GENES, RAS; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; OVARIAN NEOPLASMS;

EID: 0034655882     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00192-2     Document Type: Article

References (28)

1. Ehlen T., Dubeau L. Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas. Oncogene. 5:1990;219-223.
2. Lee J.H., Kavanagh J.J., Wildrik D.M., Wharton J.T., Blick M. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. Cancer Res. 50:1990;2724-2728.
3. Sato T., Saito H., Morita R., Koi S., Lee J.H., Nakamura Y. Allelotype of human ovarian cancer. Cancer Res. 51:1991;5118-5122.
4. Zheng J., Robinson W.R., Ehlen T., Yu M.C., Dubeau L. Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and HER-2/new gene amplification. Cancer Res. 51:1991;4045-4051.
5. Saito S., Saito H., Koi S., Sagae S., Kudo R., Saito J., Noda K., Nakamura Y. Fine-scale deletion mapping of the distal long arm chromosome 6 in 70 human ovarian cancers. Cancer Res. 52:1992;5815-5817.
6. Cliby W., Ritland S., Hartmann L., Dodson M., Haling K.C., Keeney G., Podratz K.C., Jenkins R.B. Human epithelial ovarian cancer allelotype. Cancer Res. 53:1993;2393-2398.
7. Foulkes W.D., Ragoussis J., Stamp G.W.H., Allan G.J., Trowsdale J. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer. 67:1993;551-559.
8. Wan M., Zweizig S., D'Ablaing G., Zheng J., Velicescu M., Dubeau L. Three distinct regions of chromosome 6 are targets of loss of heterozygosity in human ovarian carcinomas. Int J Oncol. 5:1994;1043-1048.
9. Orphanos V., McGown G., Hey Y., Thorncroft M., Santibanex-Koref M., Russel S.E.H., Hickey I., Atkinson R.J., Boyle J.M. Allelic imbalance of chromosome 6q in ovarian tumours. Br J Cancer. 71:1995;666-669.
10. Cooke I.E., Shelling A.N., Meuth V.G.L., Charnock F.M.L., Ganesan T.S. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer. Genes Chromosom Cancer. 15:1996;223-233.
11. Saito S., Sirahama S., Matsushima M., Suzuki M., Sagae S., Kudo R., Saito J., Noda K., Nakamura Y. Definition of a commonly deleted region in ovarian cancers to a 300-kb segment of chromosome 6q27. Cancer Res. 56:1996;5586-5589.
12. Prasad R., Gu Y., Alder H., Nakamura T., Canaani O., Saito H., Huebner K., Gale R.P., Nowell P.C., Kuriyama K., Miyazaki Y., Croce C.M., Canaani E. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res. 53:1993;5624-5628.
13. Kuriyama M., Harada N., Kuroda S., Yamamoto T., Nakafuku M., Iwamatsu A., Yamamoto D., Prasad R., Croce C., Canaani E., Kaibuchi K. Identification of AF-6 and Canoe as putative targets for Ras. J Biol Chem. 271:1996;607-610.
14. Yamamoto T., Harada N., Kano K., Taya S., Canaai E., Matsuura Y., Mizoguchi A., Ide C., Kaibuchi K. The Ras target AF-6 interacts with ZO-1 and serves as a peripheral component of tight junctions in epithelial cells. J Cell Biol. 139:1997;785-795.
15. Mok S.C.-H., Bell D.A., Knapp R.C., Fishbaugh P.M., Welch W.R., Muto M.G., Berkowitz R.S., Tsao S.-W. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res. 53:1993;1489-1492.
16. Ichikawa Y., Nishida M., Suzuki H., Yoshida S., Tsunoda H., Kubo T. Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. Cancer Res. 54:1994;33-35.
17. Fujita M., Enomoto T., Inoue M., Tanizawa O., Ozaki M., Rice J.M., Nomura T. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary. Jpn J Cancer Res. 85:1994;1247-1256.
18. Pieretti M., Cavalieri C., Conway P.S., Gallion H.H., Powell D.E., Turker M.S. Genetic alterations distinguish different types of ovarian tumors. Int J Cancer. 64:1995;434-440.
19. Sato T., Tanigami A., Yamakawa K., Akiyama F., Kasumi F., Sakamoto G., Nakamura Y. Allelotype of breast cancer. cumulative allele losses promote tumor progression in primary breast cancer Cancer Res. 50:1990;7184-7189.
20. Oka T., Matsunaga H., Tokunaga K., Mitsunaga S., Juji T., Yamane A. A simple method for detecting single base substitutions and its application to HLA-DPB 1 typing. Nucleic Acids Res. 22:1994;1541-1547.
21. Vogelstein B., Fearson E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smits A.M.M., Bos J.L. Genetic alterations during colorectal-tumor development. N Engl J Med. 319:1988;525-532.
22. Laurent-Puig P., Olschwang S., Delattre O., Validire P., Melot T., Mosseri V., Salmon R.J., Thomas G. Association of Ki-ras mutation with differentiation and tumor-formation pathways in colorectal carcinoma. Int J Cancer. 49:1991;220-223.
23. Soh K., Yanagisawa A., Hiratsuka H., Sugano H., Kato Y. Variation in K-ras codon 12 point mutation rate with histological atypia within individual colorectal tumors. Jpn J Cancer Res. 84:1993;388-393.
24. Kobayashi T., Tsuda H., Noguchi M., Hirohashi S., Shimosato Y., Goya T., Hayata Y. Association of point mutation in c-Ki-ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes. Cancer. 66:1990;289-294.
25. Westra W.H., Slebos R.J.C., Offerhaus G.J.A., Goodman S.N., Evers S.G., Kensler T.W., Askin F.B., Rodenhuis S., Hruban R.H. K-ras oncogene activation in lung adenocarcinomas from former smokers. Cancer. 72:1993;432-438.
26. Miki H., Ohmori M., Perantoni A.O., Enomoto T. K-ras activation in gastric epithelial tumors in Japanese. Cancer Lett. 58:1991;107-113.
27. Sasaki H., Nishii H., Takahashi H., Tada A., Furusato M., Terashima Y., Siegal G.P., Parker S.L., Kohler M.F., Berchuck A., Boyd J. Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Res. 53:1993;1906-1910.
28. Suzuki M., Saito S., Saga Y., Ohwada M., Sato I. Loss of heterozygosity on chromosome 6q27 and p53 mutations in epithelial ovarian cancer. Med Oncol. 15:1998;119-123.